Surgepays is trading at $0.15, down 5.08%, amid a broad selloff and rising Treasury yields, with the move appearing primarily macro-driven.
- On September 23, risk-off sentiment intensified as major U.S. indexes declined.
- No new company-specific announcement was identified on September 23; the latest notable disclosure was a non-binding September 17 joint-venture LOI with LowWeeklyPayments.
- Small-cap weakness appeared to amplify volatility.